New HCV Drugs Offer Hope After Transplant
WASHINGTON (MedPage Today) -- The advent of new all-oral regimens for hepatitis C (HCV) offers hope to patients who have undergone liver transplant and had the disease recur, a researcher said here.
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news
More News: Hepatitis | Hepatitis C | Infectious Diseases | Liver | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology